Yonglong Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yonglong Wei has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Feng Liu
Institute of Zoology, Chinese Academy of Sciences, Beijing, China
7 shared publications Lu Wang
State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
4 shared publicationsYa Gao
State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
4 shared publicationsDongyuan Ma
State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
3 shared publications- Hao Zhu
The University of Texas Southwestern Medical Center
3 shared publications Min Zhu
Children’s Research Institute and Children’s Research Institute Mouse Genome Engineering Core, University of Texas Southwestern Medical Center, Dallas, TX, USA
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Wiley in Advanced Science
Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development
Although metabolic reprogramming is a recognized hallmark of cancer, the specific metabolic pathways driving hepatocellular carcinoma (HCC) development remain incompletely understood. Through metabolomic profiling of human HCC specimens, we reveal that amino acids and their analogues are the most profoundly dysregulated metabolites, with glutamine being notably depleted within the tumor microenvironment. Despite its perception as a generic nutrient, we demonstrate that dietary glutamine supplementation promotes the malignant transformation of tumor progenitors and accelerates proliferation in oncogene‐driven murine models, ultimately compromising overall survival. Metabolomic and 13 C‐isotope tracing analyses indicate that glutamine is preferentially channeled into de novo sphingomyelin (SM) synthesis. Both genetic and pharmacological interventions establish SM as the primary downstream effector mediating glutamine's pro‐tumorigenic effects. Mechanistically, SM accumulation promotes lipid raft formation, which subsequently activates TGF‐β signaling to induce epithelial–mesenchymal transition. This cascade compromises the epithelial integrity of preneoplastic hepatocytes, thereby driving malignant transformation and fueling tumor progression. Collectively, these findings provide a mechanistic rationale cautioning against glutamine supplementation in high‐risk populations and highlight potential novel metabolic vulnerabilities for the prevention and treatment of HCC.
- 18 November 2026
- Published by Wiley in Advanced Science
Open AccessGlutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development
Although metabolic reprogramming is a recognized hallmark of cancer, the specific metabolic pathways driving hepatocellular carcinoma (HCC) development remain incompletely understood. Through metabolomic profiling of human HCC specimens, we reveal that amino acids and their analogues are the most profoundly dysregulated metabolites, with glutamine being notably depleted within the tumor microenvironment. Despite its perception as a generic nutrient, we demonstrate that dietary glutamine supplementation promotes the malignant transformation of tumor progenitors and accelerates proliferation in oncogene‐driven murine models, ultimately compromising overall survival. Metabolomic and 13 C‐isotope tracing analyses indicate that glutamine is preferentially channeled into de novo sphingomyelin (SM) synthesis. Both genetic and pharmacological interventions establish SM as the primary downstream effector mediating glutamine's pro‐tumorigenic effects. Mechanistically, SM accumulation promotes lipid raft formation, which subsequently activates TGF‐β signaling to induce epithelial–mesenchymal transition. This cascade compromises the epithelial integrity of preneoplastic hepatocytes, thereby driving malignant transformation and fueling tumor progression. Collectively, these findings provide a mechanistic rationale cautioning against glutamine supplementation in high‐risk populations and highlight potential novel metabolic vulnerabilities for the prevention and treatment of HCC.
- Open Access
- 21 October 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (20) , e71412
Iron Homeostasis and Liver Diseases
Iron is an essential micronutrient whose ability to cycle between ferric (Fe 3+ ) and ferrous (Fe 2+ ) states makes it crucial for physiological processes, including oxygen transport, DNA synthesis, and oxidative phosphorylation. However, because both deficiency and excess can cause severe pathology, precise regulation is critical. The liver plays a central role in systemic iron metabolism, and growing evidence identifies hepatic iron dyshomeostasis as a key catalyst in diverse liver disorders, including metabolic dysfunction‐associated steatotic liver disease (MASLD/MASH), alcoholic liver disease, liver fibrosis, and hepatocellular carcinoma (HCC). Hepatic iron accumulation promotes liver injury primarily through oxidative stress, mitochondrial dysfunction, and ferroptosis. In this review, we synthesize the multi‐layered regulatory landscape of hepatic iron homeostasis, encompassing systemic coordination, cellular fine‐tuning, and epigenetic modifications. We thoroughly dissect the pathogenic impact of iron overload and critically evaluate emerging therapeutic strategies aimed at restoring iron balance, such as hepcidin mimetics and ferroptosis modulators. Finally, we discuss current literature gaps—including preclinical model limitations, the lack of standardized non‐invasive biomarkers, and drug delivery bottlenecks—providing a clear roadmap for future translational research in iron‐related liver pathologies.
- 21 October 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (20) , e71412
Open AccessIron Homeostasis and Liver Diseases
Iron is an essential micronutrient whose ability to cycle between ferric (Fe 3+ ) and ferrous (Fe 2+ ) states makes it crucial for physiological processes, including oxygen transport, DNA synthesis, and oxidative phosphorylation. However, because both deficiency and excess can cause severe pathology, precise regulation is critical. The liver plays a central role in systemic iron metabolism, and growing evidence identifies hepatic iron dyshomeostasis as a key catalyst in diverse liver disorders, including metabolic dysfunction‐associated steatotic liver disease (MASLD/MASH), alcoholic liver disease, liver fibrosis, and hepatocellular carcinoma (HCC). Hepatic iron accumulation promotes liver injury primarily through oxidative stress, mitochondrial dysfunction, and ferroptosis. In this review, we synthesize the multi‐layered regulatory landscape of hepatic iron homeostasis, encompassing systemic coordination, cellular fine‐tuning, and epigenetic modifications. We thoroughly dissect the pathogenic impact of iron overload and critically evaluate emerging therapeutic strategies aimed at restoring iron balance, such as hepcidin mimetics and ferroptosis modulators. Finally, we discuss current literature gaps—including preclinical model limitations, the lack of standardized non‐invasive biomarkers, and drug delivery bottlenecks—providing a clear roadmap for future translational research in iron‐related liver pathologies.
- Top Cited Papers
- 29 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6784) , eadv7129
The origin of hepatocellular carcinoma depends on metabolic zonation
The origin of cancer is poorly understood because premalignant cells are rarely followed in their native environments. Although the spatial compartmentalization of metabolic functions is critical for proper liver function, it is unknown whether cancers arise from some zones but not others and whether there are metabolic determinants of cancer risk. Zone-specific, mosaic introduction of Ctnnb1 (catenin beta 1) and Arid2 (AT-rich interaction domain 2) mutations, commonly co-mutated genes in hepatocellular carcinoma (HCC), in mouse models showed that position and metabolic context determine clone fates. Ctnnb1 / Arid2 -driven cancers were much more likely to arise in zone 3. The zone 3 genes Gstm2 and Gstm3 were required for efficient HCC initiation, in part through inhibition of ferroptosis. In the liver, the zonal determinants of HCC development can reveal metabolic vulnerabilities of cancer.
- 29 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6784) , eadv7129
Top Cited PapersThe origin of hepatocellular carcinoma depends on metabolic zonation
The origin of cancer is poorly understood because premalignant cells are rarely followed in their native environments. Although the spatial compartmentalization of metabolic functions is critical for proper liver function, it is unknown whether cancers arise from some zones but not others and whether there are metabolic determinants of cancer risk. Zone-specific, mosaic introduction of Ctnnb1 (catenin beta 1) and Arid2 (AT-rich interaction domain 2) mutations, commonly co-mutated genes in hepatocellular carcinoma (HCC), in mouse models showed that position and metabolic context determine clone fates. Ctnnb1 / Arid2 -driven cancers were much more likely to arise in zone 3. The zone 3 genes Gstm2 and Gstm3 were required for efficient HCC initiation, in part through inhibition of ferroptosis. In the liver, the zonal determinants of HCC development can reveal metabolic vulnerabilities of cancer.
- Top Cited Papers
- 26 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6532) , 906-+
Liver homeostasis is maintained by midlobular zone 2 hepatocytes
Zoning in on liver growth: For organ homeostasis or regrowth after injury or disease, one or more stem cell populations is needed to rebuild lost tissue. There is considerable debate about the source of new cells in the liver. Two groups now identify the source of new hepatocytes (see the Perspective by Andersson). Although the liver may seem to lack major variation across its structure, its lobule is organized into concentric zones where hepatocytes express different metabolic enzymes. Wei et al. sought to systematically define the source of new liver cells by comparing 14 fate-mapping mice that label different liver cell types. They found that different regions of the liver lobule exhibit differences in hepatocyte turnover, with zone 2 representing a primary source of new hepatocytes during homeostasis and regeneration. Similarly, He et al. designed a genetic approach to record cell proliferation in vivo with high spatial and temporal resolution to enable continuous recording of proliferative events of any specific cell type at the whole-cell population level. Using this method, they identified zone 2 as having the highest proliferative activity and contributing the most to liver regrowth. These findings have implications for the cellular basis of chronic disease pathogenesis, cancer development, and regenerative medicine strategies. Science , this issue p. eabb1625 , p. eabc4346 ; see also p. 887
- 26 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6532) , 906-+
Top Cited PapersLiver homeostasis is maintained by midlobular zone 2 hepatocytes
Zoning in on liver growth: For organ homeostasis or regrowth after injury or disease, one or more stem cell populations is needed to rebuild lost tissue. There is considerable debate about the source of new cells in the liver. Two groups now identify the source of new hepatocytes (see the Perspective by Andersson). Although the liver may seem to lack major variation across its structure, its lobule is organized into concentric zones where hepatocytes express different metabolic enzymes. Wei et al. sought to systematically define the source of new liver cells by comparing 14 fate-mapping mice that label different liver cell types. They found that different regions of the liver lobule exhibit differences in hepatocyte turnover, with zone 2 representing a primary source of new hepatocytes during homeostasis and regeneration. Similarly, He et al. designed a genetic approach to record cell proliferation in vivo with high spatial and temporal resolution to enable continuous recording of proliferative events of any specific cell type at the whole-cell population level. Using this method, they identified zone 2 as having the highest proliferative activity and contributing the most to liver regrowth. These findings have implications for the cellular basis of chronic disease pathogenesis, cancer development, and regenerative medicine strategies. Science , this issue p. eabb1625 , p. eabc4346 ; see also p. 887
- 25 October 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (52) , e1805308
Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
MRNA‐mediated protein replacement represents a promising concept for the treatment of liver disorders. Children born with fumarylacetoacetate hydrolase (FAH) mutations suffer from Hepatorenal Tyrosinemia Type 1 (HT‐1) resulting in renal dysfunction, liver failure, neurological impairments, and cancer. Protein replacement therapy using FAH mRNA offers tremendous potential to cure HT‐1, but is currently hindered by the development of effective mRNA carriers that can function in diseased livers. Structure‐guided, rational optimization of 5A2‐SC8 mRNA‐loaded dendrimer lipid nanoparticles (mDLNPs) increases delivery potency of FAH mRNA, resulting in functional FAH protein and sustained normalization of body weight and liver function in FAH−/− knockout mice. Optimization using luciferase mRNA produces DLNP carriers that are efficacious at mRNA doses as low as 0.05 mg kg−1 in vivo. mDLNPs transfect > 44% of all hepatocytes in the liver, yield high FAH protein levels (0.5 mg kg−1 mRNA), and are well tolerated in a knockout mouse model with compromised liver function. Genetically engineered FAH−/− mice treated with FAH mRNA mDLNPs have statistically equivalent levels of TBIL, ALT, and AST compared to wild type C57BL/6 mice and maintain normal weight throughout the month‐long course of treatment. This study provides a framework for the rational optimization of LNPs to improve delivery of mRNA broadly and introduces a specific and viable DLNP carrier with translational potential to treat genetic diseases of the liver.
- 25 October 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (52) , e1805308
Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
MRNA‐mediated protein replacement represents a promising concept for the treatment of liver disorders. Children born with fumarylacetoacetate hydrolase (FAH) mutations suffer from Hepatorenal Tyrosinemia Type 1 (HT‐1) resulting in renal dysfunction, liver failure, neurological impairments, and cancer. Protein replacement therapy using FAH mRNA offers tremendous potential to cure HT‐1, but is currently hindered by the development of effective mRNA carriers that can function in diseased livers. Structure‐guided, rational optimization of 5A2‐SC8 mRNA‐loaded dendrimer lipid nanoparticles (mDLNPs) increases delivery potency of FAH mRNA, resulting in functional FAH protein and sustained normalization of body weight and liver function in FAH−/− knockout mice. Optimization using luciferase mRNA produces DLNP carriers that are efficacious at mRNA doses as low as 0.05 mg kg−1 in vivo. mDLNPs transfect > 44% of all hepatocytes in the liver, yield high FAH protein levels (0.5 mg kg−1 mRNA), and are well tolerated in a knockout mouse model with compromised liver function. Genetically engineered FAH−/− mice treated with FAH mRNA mDLNPs have statistically equivalent levels of TBIL, ALT, and AST compared to wild type C57BL/6 mice and maintain normal weight throughout the month‐long course of treatment. This study provides a framework for the rational optimization of LNPs to improve delivery of mRNA broadly and introduces a specific and viable DLNP carrier with translational potential to treat genetic diseases of the liver.
- Open Access
- 1 January 2018
- Published by Elsevier in Cancer Cell
- Vol. 33 (1) , 151-152
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer
- 1 January 2018
- Published by Elsevier in Cancer Cell
- Vol. 33 (1) , 151-152
Open AccessArid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer
- Open Access
- 23 March 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (3) , e0152140
A Highly Efficient and Simple Construction Strategy for Producing Recombinant Baculovirus Bombyx mori Nucleopolyhedrovirus
The silkworm baculovirus expression system is widely used to produce recombinant proteins. Several strategies for constructing recombinant viruses that contain foreign genes have been reported. Here, we developed a novel defective-rescue BmNPV Bacmid (reBmBac) expression system. A CopyControl origin of replication was introduced into the viral genome to facilitate its genetic manipulation in Escherichia coli and to ensure the preparation of large amounts of high quality reBmBac DNA as well as high quality recombinant baculoviruses. The ORF1629, cathepsin and chitinase genes were partially deleted or rendered defective to improve the efficiency of recombinant baculovirus generation and the expression of foreign genes. The system was validated by the successful expression of luciferase reporter gene and porcine interferon γ. This system can be used to produce batches of recombinant baculoviruses and target proteins rapidly and efficiently in silkworms.
- 23 March 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (3) , e0152140
Open AccessA Highly Efficient and Simple Construction Strategy for Producing Recombinant Baculovirus Bombyx mori Nucleopolyhedrovirus
The silkworm baculovirus expression system is widely used to produce recombinant proteins. Several strategies for constructing recombinant viruses that contain foreign genes have been reported. Here, we developed a novel defective-rescue BmNPV Bacmid (reBmBac) expression system. A CopyControl origin of replication was introduced into the viral genome to facilitate its genetic manipulation in Escherichia coli and to ensure the preparation of large amounts of high quality reBmBac DNA as well as high quality recombinant baculoviruses. The ORF1629, cathepsin and chitinase genes were partially deleted or rendered defective to improve the efficiency of recombinant baculovirus generation and the expression of foreign genes. The system was validated by the successful expression of luciferase reporter gene and porcine interferon γ. This system can be used to produce batches of recombinant baculoviruses and target proteins rapidly and efficiently in silkworms.
- Open Access
- 1 January 2016
- Published by The Company of Biologists in Development
- Vol. 143 (12) , 2103-2110
RNA polymerase III component Rpc9 regulates hematopoietic stem and progenitor cell maintenance in zebrafish
Hematopoietic stem and progenitor cells (HSPCs) are capable of self-renewal and replenishing all lineages of blood cells throughout the lifetime and thus critical for tissue homeostasis. However, the mechanism regulating HSPC development is still incompletely understood. Here, we isolate a zebrafish mutant with defective T lymphopoiesis and positional cloning identifies that Rpc9, a component of DNA-directed RNA polymerase III (Pol III) complex, is responsible for the mutant phenotype. Further analysis shows that rpc9-deficiency leads to the impairment of HSPCs and their derivatives in zebrafish embryos. Excessive apoptosis is observed in the caudal hematopoietic tissue (CHT, the equivalent of fetal liver in mammals) of rpc9−/− embryos and the hematopoietic defects in rpc9−/− embryos can be fully rescued by suppression of p53. Thus, our work illustrate that Rpc9, a component of Pol III, plays an important tissue-specific role in HSPC maintenance during zebrafish embryogenesis and that it might be conserved across vertebrates including mammals.
- 1 January 2016
- Published by The Company of Biologists in Development
- Vol. 143 (12) , 2103-2110
Open AccessRNA polymerase III component Rpc9 regulates hematopoietic stem and progenitor cell maintenance in zebrafish
Hematopoietic stem and progenitor cells (HSPCs) are capable of self-renewal and replenishing all lineages of blood cells throughout the lifetime and thus critical for tissue homeostasis. However, the mechanism regulating HSPC development is still incompletely understood. Here, we isolate a zebrafish mutant with defective T lymphopoiesis and positional cloning identifies that Rpc9, a component of DNA-directed RNA polymerase III (Pol III) complex, is responsible for the mutant phenotype. Further analysis shows that rpc9-deficiency leads to the impairment of HSPCs and their derivatives in zebrafish embryos. Excessive apoptosis is observed in the caudal hematopoietic tissue (CHT, the equivalent of fetal liver in mammals) of rpc9−/− embryos and the hematopoietic defects in rpc9−/− embryos can be fully rescued by suppression of p53. Thus, our work illustrate that Rpc9, a component of Pol III, plays an important tissue-specific role in HSPC maintenance during zebrafish embryogenesis and that it might be conserved across vertebrates including mammals.
- Open Access
- 15 September 2015
- Published by Springer Nature in Cell Discovery
- Vol. 1 (1) , 15027
Direct regulation of p53 by miR-142a-3p mediates the survival of hematopoietic stem and progenitor cells in zebrafish
Hematopoietic stem and progenitor cells have the capacity to self-renew and differentiate into all blood cell lineages, and thus sustain life-long homeostasis of the hematopoietic system. Although intensive studies have focused on the orchestrated genetic network of hematopoietic stem and progenitor cell specification and expansion, relatively little is known on the regulation of hematopoietic stem and progenitor cell survival during embryogenesis. Here, we generated two types of miR-142a-3p genetic mutants in zebrafish and showed that the loss-of-function mutants displayed severe reduction of hematopoietic stem and progenitor cells. Further analysis showed that the diminished proliferation and excessive apoptosis in miR-142a-3p mutants were attributed to the increased p53 signaling. Mechanistically, we demonstrated that miR-142a-3p directly targets p53 during hematopoietic stem and progenitor cell development, and the hematopoietic stem and progenitor cell survival defect in miR-142a-3p mutants could be rescued by loss of p53. Therefore, our work reveals the significance of the miR-142a-3p-p53 pathway in controlling hematopoietic stem and progenitor cell survival, and thus advances our understanding of the role of p53 in vertebrate hematopoiesis.
- 15 September 2015
- Published by Springer Nature in Cell Discovery
- Vol. 1 (1) , 15027
Open AccessDirect regulation of p53 by miR-142a-3p mediates the survival of hematopoietic stem and progenitor cells in zebrafish
Hematopoietic stem and progenitor cells have the capacity to self-renew and differentiate into all blood cell lineages, and thus sustain life-long homeostasis of the hematopoietic system. Although intensive studies have focused on the orchestrated genetic network of hematopoietic stem and progenitor cell specification and expansion, relatively little is known on the regulation of hematopoietic stem and progenitor cell survival during embryogenesis. Here, we generated two types of miR-142a-3p genetic mutants in zebrafish and showed that the loss-of-function mutants displayed severe reduction of hematopoietic stem and progenitor cells. Further analysis showed that the diminished proliferation and excessive apoptosis in miR-142a-3p mutants were attributed to the increased p53 signaling. Mechanistically, we demonstrated that miR-142a-3p directly targets p53 during hematopoietic stem and progenitor cell development, and the hematopoietic stem and progenitor cell survival defect in miR-142a-3p mutants could be rescued by loss of p53. Therefore, our work reveals the significance of the miR-142a-3p-p53 pathway in controlling hematopoietic stem and progenitor cell survival, and thus advances our understanding of the role of p53 in vertebrate hematopoiesis.
- Open Access
- 4 September 2014
- Published by American Society of Hematology in Blood
- Vol. 124 (10) , 1578-1585
Ncor2 is required for hematopoietic stem cell emergence by inhibiting Fos signaling in zebrafish
Nuclear receptor corepressors (Ncors) are important for developmental and homeostatic processes in vertebrates, which exert transcriptional repression by coordinating with histone deacetylases. However, little is known about their roles in definitive hematopoiesis. In this study, we show that in zebrafish, ncor2 is required for hematopoietic stem cell (HSC) development by repressing fos-vegfd signaling. ncor2 is specifically expressed in the aorta-gonad-mesonephros (AGM) region in zebrafish embryos. ncor2 deficiency reduced the population of HSCs in both the AGM region and T cells in the thymus. Mechanistically, ncor2 knockdown upregulated fos transcription by modulating the acetylation level in the fos promoter region, which then enhanced Vegfd signaling. Consequently, the augmented Vegfd signaling induced Notch signaling to promote the arterial endothelial fate, therefore, possibly repressing the hemogenic endothelial specification, which is a prerequisite for HSC emergence. Thus, our findings identify a novel regulatory mechanism for Ncor2 through Fos-Vegfd-Notch signaling cascade during HSC development in zebrafish embryos. Key Points Ncor2 is essential for HSC emergence in zebrafish. Ncor2 inhibits Fos-Vegfd signaling through recruitment of histone deacetylase 3 (Hdac3).
- 4 September 2014
- Published by American Society of Hematology in Blood
- Vol. 124 (10) , 1578-1585
Open AccessNcor2 is required for hematopoietic stem cell emergence by inhibiting Fos signaling in zebrafish
Nuclear receptor corepressors (Ncors) are important for developmental and homeostatic processes in vertebrates, which exert transcriptional repression by coordinating with histone deacetylases. However, little is known about their roles in definitive hematopoiesis. In this study, we show that in zebrafish, ncor2 is required for hematopoietic stem cell (HSC) development by repressing fos-vegfd signaling. ncor2 is specifically expressed in the aorta-gonad-mesonephros (AGM) region in zebrafish embryos. ncor2 deficiency reduced the population of HSCs in both the AGM region and T cells in the thymus. Mechanistically, ncor2 knockdown upregulated fos transcription by modulating the acetylation level in the fos promoter region, which then enhanced Vegfd signaling. Consequently, the augmented Vegfd signaling induced Notch signaling to promote the arterial endothelial fate, therefore, possibly repressing the hemogenic endothelial specification, which is a prerequisite for HSC emergence. Thus, our findings identify a novel regulatory mechanism for Ncor2 through Fos-Vegfd-Notch signaling cascade during HSC development in zebrafish embryos. Key Points Ncor2 is essential for HSC emergence in zebrafish. Ncor2 inhibits Fos-Vegfd signaling through recruitment of histone deacetylase 3 (Hdac3).